NT219
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NT219, covering 2024-09-19 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: NT219 Combined With Standard of Care Biologic Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]